Asthma is a complex genetic disorder characterized by chronic airway inflammation. We hypothesized that genetic polymorphisms in chemokines and their receptors alter leukocyte mobilization and may thus influence the risk and severity of childhood asthma. Distributions of the chemokine CCL2-2578G, CCL2-927C, CCR2-V64I, CX3CR1-V249I and CX3CR1-T280M receptor polymorphisms were examined in a case-control study of 121 children with asthma and 226 age-matched healthy controls and then replicated in a family study of 99 simplex families (297 individuals). The case-control study revealed that the CCL2-2578G allele was less frequent in children with than in those without asthma (P ¼ 0.0012). No association with asthma was found for the CCL2-927, CCR2 or CX3CR1 polymorphisms. The finding in the family study that the CCL2-2578G allele was transmitted less often by heterozygous parents to their children with asthma (P ¼ 0.0016) confirms the association of CCL2-2578G with asthma risk. Biochemical studies indicated that plasma CCL2 concentrations were higher in both patients (P ¼ 0.0214) and controls (P ¼ 0.001) carrying the G allele than in subjects with other polymorphisms. Both case-control and family-based studies suggest a protective effect of allele CCL2-2578G in Tunisian asthmatic children.
Introduction
Asthma is the most common chronic childhood disease, affecting up to 30% of children in some areas of the world. 1 The published data indicate an intermediate level of asthma prevalence in Tunisian school children and suggest that allergic diseases may be common in this population. 2 Asthma airway inflammation and remodelling are characterized by lymphocyte and eosinophil infiltration of the bronchial mucosa and are accompanied by structural changes including epithelial desquamation, subepithelial fibrosis, mucus gland hyperplasia, modification of the extracellular matrix and hypertrophy/ hyperplasia of smooth muscle cells. 3 Genetic and environmental factors play a significant role in its pathogenesis, by modulating the airway inflammation and remodelling processes. Both processes involve migration of inflammatory and structural cells that are important in determining the development, chronicity and severity of asthma in individual patients.
The chemokines and their receptors that orchestrate the migration of leukocytes and smooth muscle cells in inflammatory lesions are thus likely to be involved in this pathology. Their role in inflammatory processes has been inferred mainly from murine models and from their expression in human lesions, 4 but genetic epidemiology studies have also helped to document it. Accordingly, we postulated that chemokine polymorphisms that alter cell mobilization and activation may be associated with asthma risk and severity.
We and others reported an association between the chemokine polymorphism CCL5 (G-403A), which increases constitutive transcription activity by a factor of 8, 5, 6 and asthma. [7] [8] [9] However, the absence of an association between asthma and the deletion of the functional allele in CCR5-D32, the principal CCL5 receptor, 10, 11 suggests that other CCL5 receptors may be involved in this disease. A polymorphism in the distal regulatory region of the CC chemokine ligand-2 (CCL2) gene (CCL2-G2578) modulates CCL2 production, 12, 13 and is associated with a reduced risk of severe coronary artery diseases.
14 Two independent studies in Hungary reported that the chemokine CCL2-2578G allele is more frequent in children with asthma than in controls 15, 16 although a study in northern Taiwan could not replicate these findings. 17 CC chemokine receptor-2 (CCR2), the only known receptor for CCL2, is another candidate gene for asthma. A cohort study from South Korea found the CCR2-64I allele to be more common among subjects with asthma than among those without it 18 but no study has confirmed these results yet. We identified two common single-nucleotide polymorphisms (SNPs), known as V249I and T280M, in the open reading frame of the chemokine receptor CX3CR1 gene. 19 The common CX3CR1-I249 allele and its genetically linked partner, the CX3CR1-M280 allele, are associated with a reduced risk of cardiovascular diseases 20, 21 and inflammatory lung disorders. 22, 23 CX3CR1 is thus another plausible link between inflammation, airway remodelling and asthma. Recent genetic evidence suggests that minor alleles of CX3CR1 may play a protective role in asthma 23 but we could not confirm these findings in two German cohorts. 24 Because both environmental factors and ethnic origin may modify the impact of polymorphisms of chemokines and their receptors in asthma, we examined the role of these alleles in childhood asthma with both casecontrol and family-based studies in the Tunisian population. We found that asthma risk and chemokine secretion differed according to these polymorphic variants.
Results

Case-control study
The DNA from 121 unrelated children with asthma (Table 1) and 226 healthy control subjects were genotyped for the CX3CR1 249I and CX3CR1 280M, CCL2-2578G, CCL2-927C and CCR2-64I polymorphisms (Table 2 ). The studied SNPs were selected because of their functional relevance in leukocyte migration as shown in numerous reports 12, 25 and because animal models have assigned a role for these proteins in asthma development. [26] [27] [28] [29] In addition, based on HapMapreleased public data, all SNPs used in our study (except CCR2-V64I) are tagged SNPs in European and African populations. Genotype frequencies showed no deviation from Hardy-Weinberg equilibrium in either groups (data not shown). The CCL2-2578A/G and CCL2-2578G/G genotypes were less frequent in children with asthma than in healthy individuals (P ¼ 0.0063) and therefore the CCL2-2578G allele was less frequent in the case than in the control subjects (P ¼ 0.0012; OR ¼ 2.40; 95% confidence interval (CI) ¼ 1. 36-4.28) . The data indicate a dominant protective role of CCL2-2578G allele in asthma. The frequency of alleles and genotypes for CCR2-V64I, CX3CR1-V249I and -T280M and CCL2-927C was similar in both groups, which suggests that the CX3CR1 and CCR2 polymorphisms are not associated with asthma risk.
Family study
We next used a transmission disequilibrium test (TDT) design with 99 simplex families to examine the transmission of the CCL2, CCR2, CX3CR1 249I and CX3CR1 280M alleles from heterozygous parents to affected offspring, as well as genotype distributions and allele frequencies ( Table 3 ). The TDT analysis showed that preferential transmission of the CCL2-2578G allele from heterozygous parents to affected children was less frequent than that of allele A (P ¼ 0.001). In addition, the haplotype relative risk showed that the CCL2-2578G allele was transmitted less often to patients than to controls (P ¼ 0.002). These results are in concordance with the case-control study and indicate that CCL2-2578G allele is associated with asthma risk. The frequency of the allele transmitted to the child with asthma did not, however, differ from that of the non-transmitted alleles from the parents (control alleles) for any of the CCL2-927C, CCR2 and CX3CR1 gene polymorphisms.
CCL2-A2578G, asthma severity and atopy
We analysed the correlation of these polymorphisms with asthma severity. Because of the limited number of patients, we included in this analysis both the children with asthma from the family study and the cases from case-control study (Table 4 ). CCL2-2578A/G and CCL2-2578G/G genotypes were less frequent in children with severe, compared with those with mild and moderate, asthma (P ¼ 0.01; OR ¼ 0.43; 95% CI ¼ 0.21-0.88). However, the minor allele of CCL2-2578 was too rare to be informative. In addition, no significant correlation was found between either of the CCL2-927, CCR2 and CX3CR1 gene polymorphisms and the severity of the asthma in these Tunisian subjects. We also analysed the correlation of these polymorphisms with atopy, with total IgE and skin-prick test assays performed for 105 of the 220 children with asthma. In this sample, 73 were atopic and 32 were not. The frequency of alleles for the CCL2, CCR2 and CX3CR1 gene polymorphisms was similar in both groups (data not shown). 
Abbreviations: FEVI, forced expiratory volume in 1 s; FVC, forced vital capacity; ND, not determined.
Chemokine polymorphisms in childhood asthma H Chelbi et al
Plasma level of CCL2 protein and asthma We measured and compared the level of CCL2 protein in the plasma of 114 case children and 86 controls ( Figure 1 ). Plasma CCL2 protein levels were higher in the case children ( Figure 1a , Po0.0001). They were also higher in the subjects with asthma who carried the CCL2-2578A/G and CCL2-2578G/G genotypes than in those with the CCL2-2578A/A genotype (P ¼ 0.02), but did not differ significantly from those in control subjects ( Figure 1b ).
Discussion
This investigation used case-control and family-based studies in a population residing in northern Tunisia to Table 2 Distribution of genotypes for CX3CR1, CCL2 and CCR2 polymorphisms in patients with asthma (n ¼ 121) and controls (n ¼ 226) (37) 21 (17) 31 (14) 14 (11) 55 (24) 16 (13) Abbreviations: CI, confidence interval; OR, odds ratio. a 0 denotes homozygosity for the common allele, 1 denotes heterozygosity and 2 denotes homozygosity for the minor allele. *P-value obtained when comparing subjects with mild and intermittent asthma with the other patients.
Chemokine polymorphisms in childhood asthma H Chelbi et al examine the association of childhood asthma with candidate polymorphisms of some chemokine and chemokine receptor genes. Both studies showed that the CCL2-2578G allele was associated with a reduced risk of childhood asthma in Tunisia. In contrast, CCR2 and CX3CR1, the other polymorphisms for which we tested, had no effect on asthma. Interestingly, plasma CCL2 levels were higher in patients with the CCL2-2578G allele than in other genotypes. This finding suggests that increased CCL2 production may be responsible for the protective role of the allele in asthma pathogenesis. Reproducing genetic associations reported for multifactorial diseases is rather a complex and often frustrating task. Many reasons (small sample size, poor study design, heterogeneity in classification outcomes and the ethnic origins of the study populations) may explain the failure to confirm initial reports, and guidelines to optimize these studies have been proposed. 30 The failure of this study to uncover any association between CX3CR1 polymorphisms and childhood asthma in the Tunisian population provides support for our previous data in a German population. On the other hand, Tremblay et al. 23 report significant associations between CX3CR1 polymorphisms and asthma in two Canadian studies. Similarly, Hall et al. 31 report that CCR5-D32 is associated with a reduced risk of asthma in Scottish children but further studies have found no genetic evidence to support this hypothesis. 10, 11 Because of its low frequency in the Tunisian population, the CCR5D32 allele could not be assessed in our study. Although the polymorphism of the CCL2 receptor (CCR2-64I) was not associated with childhood asthma in either the casecontrol or the family study, numerous animal models indicate that the CCL2/CCR2 axis may play a major role in asthma [26] [27] [28] [29] and that it is a potential target for therapeutic intervention. 32, 33 These discordances highlight once again the importance of the homogeneity of the study population, its genetic background and its exposure to environmental factors.
A few studies have already assessed the role of CCL2 in childhood asthma in case-control studies that examine genetic associations. In contrast to our results, the CCL2-2578G allele frequency was more frequent in subjects with asthma than in control subjects in two studies of Hungarian populations, 15, 16 one of which also found the CCL2-2578G allele to be associated with asthma severity. 15 Furthermore, a Chinese case-control study did not detect any association with childhood asthma. 17 Possible explanations for these discrepancies among the different studies include the inclusion criteria, origins of the study populations and small sample sizes. For instance, cases were up to 18 years old in the Hungarian study but did not exceed 10 years of age in the Chinese study. CCL2-2578G allele frequency differs significantly in control samples from Tunisia, Hungary and Taiwan ranging from about 51% in the Chinese population to 21% in the Hungarian. Such discrepancies have also been observed for polymorphisms in the promoter region of another chemokine named CCL5 (or RANTES). The frequency of the A allele at position À403 of the CCL5 promoter region was lowest in the Tunisian (13.4%), compared with that of the Hungarian (16.5%), Chinese (24.8%) and Japanese (37.6%) populations. 9 Similarly, the frequency of the G allele at position À28 of the CCL5 promoter region was lower in the Tunisian (8.7%) than in the Chinese population (10.6-11.7%) 34, 35 but higher than that in an African-American population (0%). 36 These reports reveal the ethnic diversity in allelic frequencies of these chemokine genes.
Ethnically, Tunisia has been inhabited by Berber tribes since recorded history began. Numerous waves of invasion and immigration have also passed through it, from as far away as the Caucasus and China. Therefore, susceptibility studies of multifactorial disorders such as asthma should be performed among specific ethnic groups. In addition to genetic background, numerous environmental factors and dietary variations make difficult to compare these populations regarding their genetic susceptibility or asthma.
To replicate the positive result found in the casecontrol study, we used a sample of 99 families to test whether the CCL2-2578G allele is also less transmitted from parents to their asthmatic children; according to both the TDT and the haplotype relative risk analyses, it was. These data strongly support the association of childhood asthma with CCL2-2578G observed in the case-control study and reduce the possibility of bias due to population stratification: the TDT avoids the bias generated by this stratification by using as a control group an 'internal' group constituted of the alleles not transmitted to the patient. The alleles in this group come from the same individuals and thus reduce skewed estimates. 37 TDT analysis can reportedly detect genes with weak effects 38 thereby reducing the possibility of spurious association due to population heterogeneity. 39 Additional SNPs in CCL2 gene were studied by McDermott et al. 40 but high linkage disequilibrium for CCL2-2835A, CCL2-2578G, CCL2-2136T and CCL2 þ 764G prevented to delineate their specific impact in genetic association. Because CCL2-2578G was the only SNP with functional relevance demonstrated in vitro, 12, 13 we chose to restrict our study on this SNP. However, additional uncharted SNPs may be physiologically relevant in the Tunisian population.
To investigate the functional relevance of the CCL2 genotype, we tested correlations between plasma CCL2 levels and genotypes in children with asthma and their healthy controls. CCL2 is produced by a wide variety of cells, including monocyte/macrophages, lymphocytes, fibroblasts, endothelial and epithelial cells, neutrophils, mast cells and dendritic cells, all of which are involved in airway remodelling and can contribute to recruitment of CCL2-sensitive cells (monocytes, T cells, dendritic cells and neutrophils) both to and within the airways of the lungs.
41
CCL2 mediates airway hyperactivity in normal and allergic mice and directly induces in vitro pulmonary mast cell degranulation. 42 Several human studies demonstrate the upregulation of CCL2 during asthmatic responses, 43, 44 and CCL2 protein expression in bronchial tissue is significantly higher in subjects with asthma than in control subjects. 43 In our study, plasma CCL2 protein levels were higher in the case than in the control group. This observation is consistent with the studies mentioned above and also with the data reported in children with interstitial lung diseases. 45 Keszei et al.
16
, however, found lower plasma CCL2 levels in Hungarian children with asthma. Our results are consistent with previous data showing a correlation between the CCL2-2578G allele and upregulation of CCL2 expression in response to an inflammatory stimulus 12 and in inflammatory diseases such as HIV, 13 Behcet 46 and atherosclerosis. 47 On the basis of recent report by McDermott et al.
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, CCL2 levels were associated with age, cigarette smoking, triglycerides, body mass index and waist-to-hip ratio, but these factors explained only 6% of the variability in CCL2 levels. The relevance of these parameters in children is currently unknown. As expected in inflammatory conditions, nuclear factor-kB and activator protein-1 transcription factors were shown to coordinate transcription of many chemokines including CCL2. 48, 49 However, the precise molecular mechanisms regulating CCL2 secretion in individuals bearing genetic variations in the CCL2 promoter region are currently not known.
Other factors such as nutritional habits, local environment and infections are undoubtedly involved in the regulation of chemokine production, but their interactions with promoter polymorphisms is not known. The mechanisms by which high plasma CCL2 levels may alleviate asthma risk remain to be elucidated. Possible explanations include the redistribution of CCR2-positive populations such as monocytes and mast cells from lung tissue to blood and skewed polarization towards Th1 immune responses.
The study presented here is, to our knowledge, the first to combine case-control and family-based association investigations to assess the relation between CCL2-2578A/G and childhood asthma. Interestingly, children with asthma expressed higher levels of plasma CCL2 than healthy individuals. Our findings strongly suggest a protective role for the CCL2-2578G allele in terms of susceptibility but not severity in Tunisian asthmatic children.
Patients and methods
Study subjects Case-control study. A total of 121 children were recruited from the Department of Paediatric and Respiratory Diseases of the A Mami Pneumology Hospital in Tunisia and 226 age-matched healthy control children (Table 1) . Asthma was diagnosed and classified according to GINA criteria (Global Initiative for Asthma, Report 2006, www.ginasthma.org). Standardized questionnaires were used to collect data about the children and their history: age, sex, exposure to tobacco smoke and family history of asthma and allergy. In the control group, none had any recent illness requiring treatment and no history of chronic diseases. All lived in a rural town (Ariana) near Tunis. This region is generally considered to be representative of the general Tunisian population. All data and sample collections for this study were approved by the Tunisian National Ethics Committee. Parental consent was obtained for all blood samples taken from asthmatic or healthy control children.
Family-based study. The probands were children with asthma, recruited from the Department of Paediatric and Respiratory Diseases at the A Mami Pneumology Hospital in Tunisia. A full oral and written explanation of the study was given to all family members interviewed from 99 simplex families: all 297 subjects provided informed consent to participation in this study, including provision of blood samples. Parents all consented to the taking of blood samples from the children. All families were composed of two parents and one affected child. Each family member was questioned about allergic symptoms and was examined by a participating paediatrician (Table 1) . All data and sample collections for this study were approved by Tunisian National Ethics Committee.
Total IgE and skin-prick test assays Atopy was defined by skin sensitivity to specific allergens (skin reaction with a mean weal diameter X3 mm larger than that produced with one or more antigens in the presence of a positive histamine control and a negative uncoated control) and by measurement of the total IgE level. Positive values were defined as X200 U ml -1 . In all, 105 of 220 children with asthma were evaluated for atopy analysis by both tests. In all, 73 children had atopic responses and 32 negative skin test responses to common allergens.
with minor groove binder PCR-based amplification technology from Applied Biosystems (Applied Biosystems Division, Cheshire, UK) as previously described. 19 Real-time detection and analyses were performed on an ABI 7700 thermocycler (Applied Biosystems).
Quantification of monocyte chemoattractant protein-1 Plasma levels of CCL2 were measured by enzyme-linked immunosorbent assay (human CCL2 Quantikine Immunoassay; R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions. For technical reasons, mainly due to the conditions of collection and storage, we only had access to plasma of 114 out of 220 asthma patients and to 86 out of 226 healthy controls.
Statistical analyses All genotypes were tested for Hardy-Weinberg equilibrium. All comparisons in the case-control study used the standard w 2 test with 95% CIs (GraphPad Prism 4.0). Correction for multiple comparisons was performed, and only a corrected value of Po0.05 was considered to be significant. Tests for family-based association used the haplotype relative risk and the TDT programs from the ANALYZE package. 50 For one multiplex family that was studied, only the transmission to the first affected child in the family was considered. We tested whether the genotype frequencies at unlinked loci were independent (CCL2-2578 on chromosome 17q11.2 and CCR2-64I on chromosome 3p21.31). For this reason, we compared these frequencies of each pair of unlinked SNPs in patients and controls, calculating w 2 and the corresponding P-value.
For plasma CCL2 level comparison, normality test (Kolmogorov-Smirnov test) was performed on each groups. Depending on whether distribution was normal or not, unpaired t-test and nonparametric Mann-Whitney test were used to compare groups.
